iCAN (international Children Advisory Network) fourth annual Research & Advocacy Summit will take place on July 9-13, 2018 in Edinburgh and for the first time the members of KIDS Bari, the first Italian YPAG (Young Patient Advisory Group), and KIDS Albania will...
On 7th-8th June 2018, the European Network of Paediatric Research at EMA (Enpr-EMA) will hold its tenth annual workshop, bringing relevant stakeholders together to discuss requirements, barriers and opportunities for the conduct of high-quality clinical studies in...
On 22nd May 2018, the Third National Clinical Trial Day was held in Prague under the auspices of the Vice-chairman of the Committee on Health and Social Policy of the Senate of the Parliament of the Czech Republic, with the cooperation of Czech Clinical Research...
On 8-9 March 2018, the European Medicines Agency (EMA) held “the Second International Awareness Session for international regulators, academia and non-governmental organisations”. The meeting provided the occasion to present an overall overview on how the European...
The next meeting of the ID-EPTRI (European Paediatric Translational Research Infrastructure) project, entitled “EPTRI: una nuova Infrastruttura Europea per favorire la Ricerca Traslazionale in Pediatria” (EPTRI: a new European Research Infrastructure to foster the...
In February 2018, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization in the European Union for Amglidia, a medicine indicated for the treatment of neonatal diabetes mellitus...
TEDDY Network is pleased to support the Rare Disease Day 2018, that took place on February 28th, to raise awareness of rare diseases and their impact on patients' lives amongst the general public and decision-makers. The Rare Disease Day was first launched...
The European Medicines Agency (EMA) has published on EMA’s website and on the official EMA YouTube channel, three video animations to explain how it ensures that medicines are effective and safe for the benefit of patients across the European Economic Area (EEA). The...
In October 2017, the European Commission presented to the European Parliament and the Council a comprehensive report on progress made in children’s medicines 10 year after the Paediatric Regulation came into force. The Paediatric Regulation, adopted in 2006, aims to...
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is a network of research networks, investigators and centres with recognised expertise in performing clinical studies in children. Enpr-EMA main objective is to facilitate studies...